Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families (Q43581873)

24 November 2017

Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families (English)

1 reference

24 November 2017

1 reference

Emily P Slater

1

1 reference

24 November 2017

Peter Langer

2

1 reference

24 November 2017

Volker Fendrich

3

1 reference

24 November 2017

Nils Habbe

4

1 reference

24 November 2017

Brunhilde Chaloupka

5

1 reference

24 November 2017

Elvira Matthäi

6

1 reference

24 November 2017

Mercedes Sina

7

1 reference

24 November 2017

Stephan A Hahn

8

1 reference

24 November 2017

Detlef K Bartsch

9

1 reference

24 November 2017

1 September 2010

1 reference

24 November 2017

1 reference

24 November 2017

9

1 reference

24 November 2017

3

1 reference

24 November 2017

335-343

1 reference

https://scigraph.springernature.com/pub.10.1007/s10689-010-9329-6

24 November 2017

0 references

cites work

Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region.

1 reference

12 December 2020

Hereditary diffuse gastric cancer: diagnosis, genetic counseling, and prophylactic total gastrectomy

1 reference

12 December 2020

High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families

1 reference

12 December 2020

No evidence for germline mutations of the LKB1/STK11 gene in familial pancreatic carcinoma

1 reference

12 December 2020

Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer

1 reference

12 December 2020

Advances in counselling and surveillance of patients at risk for pancreatic cancer

1 reference

12 December 2020

German National Case Collection of Familial Pancreatic Cancer – Clinical-Genetic Analysis of the First 21 Families

1 reference

12 December 2020

Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion ofp16 (p16-Leiden)

1 reference

12 December 2020

Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.

1 reference

12 December 2020

Genetic testing. Counseling, laboratory, and regulatory issues and the EUROPAC protocol for ethical research in multicenter studies of inherited pancreatic diseases.

1 reference

12 December 2020

BRCA2 germline mutations in familial pancreatic carcinoma

1 reference

12 December 2020

Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions

1 reference

12 December 2020

The prevalence of BRCA2 mutations in familial pancreatic cancer

1 reference

12 December 2020

Update of Familial Pancreatic Cancer in Germany

1 reference

12 December 2020

Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas

1 reference

12 December 2020

Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population

1 reference

12 December 2020

Cancer risks in BRCA2 mutation carriers

1 reference

12 December 2020

Genetics of pancreatic cancer. From genes to families.

1 reference

12 December 2020

Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer

1 reference

12 December 2020

Association of the I1307K APC mutation with hereditary and sporadic breast/ovarian cancer: more questions than answers

1 reference

12 December 2020

Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome

1 reference

12 December 2020

Differences in the frequency and distribution of BRCA1 and BRCA2 mutations in breast/ovarian cancer cases from the Basque country with respect to the Spanish population: implications for genetic counselling.

1 reference

12 December 2020

Recent discoveries in cancer genetics of exocrine pancreatic neoplasia

1 reference

12 December 2020

Evaluation of BRCA2 in the genetic susceptibility of familial esophageal cancer

1 reference

12 December 2020

Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome

1 reference

12 December 2020

Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations

1 reference

12 December 2020

Genetic counseling and testing for germline p16 mutations in two pancreatic cancer-prone families

1 reference

12 December 2020

RNASEL germline variants are associated with pancreatic cancer

1 reference

12 December 2020

Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer.

1 reference

12 December 2020

Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations

1 reference

12 December 2020

[Familial pancreatic cancer--concept for study of the National Case Collection and early diagnosis program for high risk people]

1 reference

12 December 2020

CDKN2A germline mutations in familial pancreatic cancer

1 reference

12 December 2020

Familial pancreatic cancer

1 reference

12 December 2020

Anticipation in familial pancreatic cancer.

1 reference

12 December 2020

Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients

1 reference

12 December 2020

Tumor-suppressive pathways in pancreatic carcinoma.

1 reference

12 December 2020

Increased Risk of Pancreatic Cancer in Melanoma-Prone Kindreds withp16INK4Mutations

1 reference

12 December 2020

In vivo therapeutic responses contingent on Fanconi anemia/BRCA2 status of the tumor

1 reference

12 December 2020

Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds

1 reference

12 December 2020

Low frequency of CHEK2 mutations in familial pancreatic cancer

1 reference

12 December 2020

Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.

1 reference

12 December 2020

Mutations associated with familial melanoma impair p16INK4 function.

1 reference

12 December 2020

10.1007/S10689-010-9329-6

Identifiers

DOI

1 reference

24 November 2017

1 reference